Nanomedicine Drug Delivery
Nanoscale carriers such as liposomes, polymer particles, and lipid nanoparticles used to protect, target, or control medicines in the body.
Core metadata
- ID: nanomedicine_drug_delivery
- Era: Modern
- First known date: 1995 (decade)
- Region: Global pharmaceutical research and nanomedicine
- Review status: source_checked
- Maturity: established
Prerequisites
- Lipid Nanoparticles (lipid_nanoparticles)
- Nanotechnology (Early Research) (nanotechnology_early)
- Polymer Chemistry (polymer_chemistry)
Dependents
- None.
Fields
Field lanes
- Pharmaceuticals & Drug Development: Drug Delivery & Formulation
Node sources
- Lipid nanoparticles for mRNA delivery (PubMed, 2021, review) • Supports: node, maturity
- Cellular and Gene Therapy Products (U.S. Food and Drug Administration, 2026, official_agency) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 70%
- Prerequisite sources: 3
- expert_inference: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Lipid Nanoparticles (lipid_nanoparticles) | enabling | 68% | expert_inference | Lipid Nanoparticles provides a capability that enables this technology without being the only possible path. |
|
| Nanotechnology (Early Research) (nanotechnology_early) | historical_predecessor | 75% | expert_inference | Nanotechnology (Early Research) is an earlier historical predecessor or foundation, not a one-to-one engineering dependency. |
|
| Polymer Chemistry (polymer_chemistry) | enabling | 68% | expert_inference | Polymer Chemistry provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.